SBI Life Insurance Approves Grant of 8,94,910 Stock Options Under ESOS-2018 Scheme
SBI Life Insurance Company Ltd announced the approval of a significant grant of stock options to its employees under the Employee Stock Option Scheme -2018 (ESOS-2018 Scheme). The decision was made by the company's Board Nomination and Remuneration Committee during a meeting held on July 13, 2026.The committee approved the grant of 8,94,910 options to eligible employees of the Company. Each option entitles the holder to one equity share of the Company at Rs. 10/- upon exercise. The entire issuance covers a total of 8,94,910 equity shares valued at Rs. 10 each.
The grant adheres to the provisions of SEBI (Share Employees Benefits and Sweat Equity) Regulations, 2021. Details regarding the options under the ESOS-2018 Scheme are summarized below:
| Detail | Specification |
|---|---|
| Total Options Granted | 8,94,910 |
| Entitlement Per Option | One equity share of Rs. 10/- |
| Eligibility Status | Eligible employees |
| Shares Covered | 8,94,910 equity shares at Rs. 10 each |
A key element of the scheme is the pricing formula for option exercise. The exercise price will be determined as the lower of the Fair Market Value (FMV) recorded on the grant date or the Average Fair Market Value calculated over the 15 trading days immediately preceding the grant date.
The options have a defined vesting structure and term limit. Vesting is set at a tiered proportion of 30%–30%–40%, with vesting commencing one year after the option grant date. Furthermore, employees are allotted seven years to exercise the said Options from the date of grant.
SBILIFE Stock Price Movement
As of 1:12 PM, shares of SBI Life Insurance Company Limited are slipping by 0.59% in live trading, currently priced at ₹1851.9. The stock has registered a volume of 201,103 shares so far today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.